pharmaceutical industry

Analysis

A House of Cards? Is the rise in the pharmaceutical industry’s reputation here to stay?

COVID-19 has shone a spotlight on the pharmaceutical industry, which is now enjoying increased levels of visibility and trust amongst the public, healthcare professionals and policymakers alike. How c... Read more

Analysis

The transformation of global pharma’s Government Affairs functions

The pandemic has changed what policymakers expect from the pharma industry. How can global Government Affairs teams respond?... Read more